The trademark ALTUVIO was filed by Swedish Orphan Biovitrum AB (publ), a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on October 6, 2021, and received one opposition filed on January 5, 2022 by Novartis AG on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 5, 2022
The application was filed in Swedish, and Swedish was also language of all opposition proceedings (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on February 3, 2022.